Amalgamated Financial’s Eli Lilly LLY Stock Holding History

Amalgamated Financial’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$64.8M	Buy	+226,407	New	+$58.3M	0.51%	25

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Amalgamated Financial's LLY Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Eli Lilly (LLY) in Q1 2022: 226,407 shares worth $64.8M. The stake represents 0.51% of the portfolio and ranks #25 among its holdings.

2,346 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

Amalgamated Financial held 226,407 shares of Eli Lilly worth $64.8M as of Q1 2022.
Eli Lilly was a new Amalgamated Financial position in Q1 2022.
Eli Lilly made up 0.51% of Amalgamated Financial's portfolio in Q1 2022, its #25 holding.
2,346 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.